We provide you with 20 years of free, institutional-grade data for RENB stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RENB. Explore the full financial landscape of RENB stock.
| Reported Date | CIK | Ticker | Type |
|---|
Renovaro Biosciences Inc(NASDAQ:RENB) 
Renovaro Biosciences Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer. The company's product pipeline includes ENOB-HV...
Website: https://www.enochianbio.com/
Founded: 2011
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Share this website to your friends
The information provided in this report about RENB stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.